Companies
Pfizer
S&P 500Health Care· USA

PFE

Challenger

Pfizer

$27.34

+1.60%

Open $26.83·Prev $26.91

as of 13 Apr

CHALLENGER

Power Core

Pfizer's moat is its global manufacturing and commercialization infrastructure, which allows it to scale novel therapeutics from approval to multi-billion-dollar revenue faster than nearly any competitor.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral With Downward Pressure From Multiple Vectors

ROC 200

+16.1%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
PFE — Pfizer — Power Mapping Analysis — L17X — L17X